Siokas V., Dardiotis E., Sokolakis T., Kotoula M., Tachmitzi S.V., Chatzoulis D.Z., Almpanidou P., Stefanidis I., Hadjigeorgiou G.M., Tsironi E.E. (2017)
Background: There is accumulating evidence for genetic susceptibility to the development of diabetic retinopathy (DR). The role of plasminogen activator inhibitor-1 (PAI-1) in DR risk remains controversial. Objective: The ...